首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
【24h】

Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.

机译:多种维生素中的β-胡萝卜素以及吸烟者与以前吸烟者之间可能患肺癌的风险:对国家品牌的荟萃分析和评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Some studies have suggested that beta-carotene supplementation may increase the risk of lung cancer, particularly among smokers or former smokers. Beta-carotene, a provitamin A, is available in multivitamins. In the current study, the authors investigated the risk of lung cancer associated with beta-carotene in smokers or former smokers and surveyed the beta-carotene content in national brand multivitamins. METHODS: The authors systemically reviewed the published literature using a search of the MEDLINE database and performed a meta-analysis of large randomized trials that reported on the effect of beta-carotene supplementation on the incidence of lung cancer among smokers or former smokers. A sample of multivitamins was evaluated for their beta-carotene content and the suggested daily dosage. RESULTS: Four studies contributing 109,394 subjects were available for analysis. The average daily beta-carotene dosage in these trials ranged from 20 to 30 mg daily. Among current smokers, beta-carotene supplementation was found to be significantly associated with an increased risk of lung cancer (odds ratio [OR], 1.24; 95% confidence interval [95% CI], 1.10-1.39). Among former smokers, there was no significant increase noted (OR, 1.10; 95% CI, 0.84-1.45). In a sample of 47 common multivitamins, beta-carotene was present in 70% of the identified formulas. The median dosage of beta-carotene was 0.3 mg (range, 0-17.2 mg) daily. The beta-carotene content was found to be significantly higher among multivitamins sold to improve visual health than among other multivitamins, with a median daily dosage of 3 mg (range, 0-24 mg). CONCLUSIONS: High-dose beta-carotene supplementation appears to increase the risk of lung cancer among current smokers. Although beta-carotene was prevalent in multivitamins, high-dose beta-carotene was observed among multivitamin formulas sold to promote visual health.
机译:背景:一些研究表明,补充β-胡萝卜素可能会增加患肺癌的风险,尤其是在吸烟者或以前的吸烟者中。 β-胡萝卜素,一种维生素原A,可在多种维生素中获得。在当前的研究中,作者调查了吸烟者或以前吸烟者与β-胡萝卜素相关的肺癌风险,并调查了国家牌复合维生素中β-胡萝卜素的含量。方法:作者使用MEDLINE数据库搜索系统地回顾了已发表的文献,并对大型随机试验进行了荟萃分析,该试验报告了补充β-胡萝卜素对吸烟者或以前吸烟者的肺癌发生率的影响。评估了多种维生素样品的β-胡萝卜素含量和建议的每日剂量。结果:共有109,394名受试者的四项研究可供分析。在这些试验中,平均每日β-胡萝卜素剂量为每天20至30 mg。在目前的吸烟者中,发现补充β-胡萝卜素与肺癌风险显着相关(比值比[OR]为1.24; 95%可信区间[95%CI]为1.10-1.39)。在以前的吸烟者中,没有发现明显的增加(OR,1.10; 95%CI,0.84-1.45)。在47种常见的多种维生素样品中,β-胡萝卜素存在于70%的确定配方中。 β-胡萝卜素的中位剂量为每天0.3 mg(范围为0-17.2 mg)。发现在为改善视觉健康而出售的多种维生素中,β-胡萝卜素含量明显高于其他多种维生素,其每日平均剂量为3 mg(0-24 mg)。结论:大剂量补充β-胡萝卜素似乎增加了目前吸烟者患肺癌的风险。尽管β-胡萝卜素广泛存在于多种维生素中,但在为促进视觉健康而出售的多种维生素配方中仍观察到高剂量的β-胡萝卜素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号